FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801291604> ?p ?o ?g. }

• W2801291604 abstract "Stereotactic body radiotherapy (SBRT) is an emerging treatment option for liver metastases in patients unsuitable for surgery. We investigated factors associated with clinical outcomes for liver metastases treated with SBRT from a multi-center, international patient registry. Patients with liver metastases treated with SBRT were identified in the RSSearch® Patient Registry. Patient, tumor and treatment characteristics associated with treatment outcomes were assessed. Dose fractionations were normalized to BED10. Overall survival (OS) and local control (LC) were evaluated using Kaplan Meier analysis and log-rank test. The study included 427 patients with 568 liver metastases from 25 academic and community-based centers. Median age was 67 years (31–91 years). Colorectal adenocarcinoma (CRC) was the most common primary cancer. 73% of patients received prior chemotherapy. Median tumor volume was 40 cm3 (1.6–877 cm3), median SBRT dose was 45 Gy (12–60 Gy) delivered in a median of 3 fractions [1–5]. At a median follow-up of 14 months (1–91 months) the median overall survival (OS) was 22 months. Median OS was greater for patients with CRC (27 mo), breast (21 mo) and gynecological (25 mo) metastases compared to lung (10 mo), other gastro-intestinal (GI) (18 mo) and pancreatic (6 mo) primaries (p < 0.0001). Smaller tumor volumes (< 40 cm3) correlated with improved OS (25 months vs 15 months p = 0.0014). BED10 ≥ 100 Gy was also associated with improved OS (27 months vs 15 months p < 0.0001). Local control (LC) was evaluable in 430 liver metastases from 324 patients. Two-year LC rates was better for BED10 ≥ 100 Gy (77.2% vs 59.6%) and the median LC was better for tumors < 40 cm3 (52 vs 39 months). There was no difference in LC based on histology of the primary tumor. In a large, multi-institutional series of patients with liver metastasis treated with SBRT, reasonable LC and OS was observed. OS and LC depended on dose and tumor volume, while OS varied by primary tumor. Future prospective trials on the role of SBRT for liver metastasis from different primaries in the setting of multidisciplinary management including systemic therapy, is warranted. Clinicaltrials.gov: NCT01885299 ." @default.
• W2801291604 created "2018-05-17" @default.
• W2801291604 creator A5007170568 @default.
• W2801291604 creator A5016732255 @default.
• W2801291604 creator A5019661851 @default.
• W2801291604 creator A5031400806 @default.
• W2801291604 creator A5033886756 @default.
• W2801291604 creator A5039691793 @default.
• W2801291604 creator A5063095503 @default.
• W2801291604 creator A5071938424 @default.
• W2801291604 creator A5076285367 @default.
• W2801291604 creator A5088992361 @default.
• W2801291604 date "2018-02-13" @default.
• W2801291604 modified "2023-10-15" @default.
• W2801291604 title "Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry" @default.
• W2801291604 cites W1501842160 @default.
• W2801291604 cites W1514079854 @default.
• W2801291604 cites W1658223714 @default.
• W2801291604 cites W1867537813 @default.
• W2801291604 cites W1895794010 @default.
• W2801291604 cites W1966703018 @default.
• W2801291604 cites W1974441098 @default.
• W2801291604 cites W1981126206 @default.
• W2801291604 cites W1982615453 @default.
• W2801291604 cites W2009947337 @default.
• W2801291604 cites W2022980644 @default.
• W2801291604 cites W2031811526 @default.
• W2801291604 cites W2034924805 @default.
• W2801291604 cites W2039467075 @default.
• W2801291604 cites W2060827509 @default.
• W2801291604 cites W2066040529 @default.
• W2801291604 cites W2069506836 @default.
• W2801291604 cites W2069529206 @default.
• W2801291604 cites W2080690097 @default.
• W2801291604 cites W2091654358 @default.
• W2801291604 cites W2097593062 @default.
• W2801291604 cites W2100699934 @default.
• W2801291604 cites W2101479540 @default.
• W2801291604 cites W2101815035 @default.
• W2801291604 cites W2105612888 @default.
• W2801291604 cites W2110735504 @default.
• W2801291604 cites W2112579119 @default.
• W2801291604 cites W2113248775 @default.
• W2801291604 cites W2119019670 @default.
• W2801291604 cites W2121304497 @default.
• W2801291604 cites W2132041828 @default.
• W2801291604 cites W2134440079 @default.
• W2801291604 cites W2138398573 @default.
• W2801291604 cites W2144326782 @default.
• W2801291604 cites W2165789184 @default.
• W2801291604 cites W2166459387 @default.
• W2801291604 cites W2167561054 @default.
• W2801291604 cites W2170366300 @default.
• W2801291604 cites W2310586570 @default.
• W2801291604 cites W2473185806 @default.
• W2801291604 cites W2555236438 @default.
• W2801291604 cites W2570618306 @default.
• W2801291604 cites W2583694869 @default.
• W2801291604 cites W2591795640 @default.
• W2801291604 cites W3192964161 @default.
• W2801291604 cites W4239112513 @default.
• W2801291604 cites W4240340450 @default.
• W2801291604 cites W4248389354 @default.
• W2801291604 cites W4362211014 @default.
• W2801291604 cites W4366305920 @default.
• W2801291604 doi "https://doi.org/10.1186/s13014-018-0969-2" @default.
• W2801291604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5811977" @default.
• W2801291604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29439707" @default.
• W2801291604 hasPublicationYear "2018" @default.
• W2801291604 type Work @default.
• W2801291604 sameAs 2801291604 @default.
• W2801291604 citedByCount "126" @default.
• W2801291604 countsByYear W28012916042018 @default.
• W2801291604 countsByYear W28012916042019 @default.
• W2801291604 countsByYear W28012916042020 @default.
• W2801291604 countsByYear W28012916042021 @default.
• W2801291604 countsByYear W28012916042022 @default.
• W2801291604 countsByYear W28012916042023 @default.
• W2801291604 crossrefType "journal-article" @default.
• W2801291604 hasAuthorship W2801291604A5007170568 @default.
• W2801291604 hasAuthorship W2801291604A5016732255 @default.
• W2801291604 hasAuthorship W2801291604A5019661851 @default.
• W2801291604 hasAuthorship W2801291604A5031400806 @default.
• W2801291604 hasAuthorship W2801291604A5033886756 @default.
• W2801291604 hasAuthorship W2801291604A5039691793 @default.
• W2801291604 hasAuthorship W2801291604A5063095503 @default.
• W2801291604 hasAuthorship W2801291604A5071938424 @default.
• W2801291604 hasAuthorship W2801291604A5076285367 @default.
• W2801291604 hasAuthorship W2801291604A5088992361 @default.
• W2801291604 hasBestOaLocation W28012916041 @default.
• W2801291604 hasConcept C121608353 @default.
• W2801291604 hasConcept C126322002 @default.
• W2801291604 hasConcept C126838900 @default.
• W2801291604 hasConcept C143998085 @default.
• W2801291604 hasConcept C2776651944 @default.
• W2801291604 hasConcept C2779013556 @default.
• W2801291604 hasConcept C2780387249 @default.
• W2801291604 hasConcept C509974204 @default.
• W2801291604 hasConcept C526805850 @default.
• W2801291604 hasConcept C71924100 @default.

• next